D’Souza, D.C., Cortes-Briones, J., Creatura, G., Bluez, G., Thurnauer, H., Deaso, E., et al. (2019) Efficacy and Safety of a Fatty Acid Amide Hydrolase Inhibitor (PF-04457845) in the Treatment of Cannabis Withdrawal and Dependence in Men: A Double-Blind, Placebo-Controlled, Parallel Group, Phase 2a Single-Site Randomised Controlled Trial. The Lancet Psychiatry, 6, 35-45.
https://doi.org/10.1016/s2215-0366(18)30427-9

has been cited by the following article:

• TITLE: The Modulating Role of Cannabis in Insomnia: A Review of the Literature

  AUTHORS: Ana Carolina Perin Spenassato, Manoella Feltrin Orsato, Márcio Silveira Correa

  KEYWORDS: Cannabis, Cannabidiol, Tetrahidrocanabinol, Insomnia, Endocannabinoid

  JOURNAL NAME: Journal of Behavioral and Brain Science, Vol.14 No.9, September 30, 2024

  ABSTRACT: The objective of this study was to carry out a review of the literature covering the topic of the association between sleep, insomnia and the medicinal use of cannabis. The guiding question for carrying out this study was whether the medicinal use of cannabis could have a significant positive impact on reducing insomnia. To this end, a review of the literature on the topic was prepared, both in English and Portuguese, from 2005 to 2023, in the PubMed, Scielo and LILACS databases. To search the databases, the keywords “cannabis”, “cannabidiol”, “tetrahydrocannabinol”, “insomnia” and “endocannabinoid” were used. In total, the initial search resulted in 17 articles. After a more careful analysis, only 6 of these articles met the inclusion criteria established for this study. Thus, it was concluded that, although some studies link the use of medicinal cannabis with an improvement in sleep quality, the current literature still lacks more studies on the topic.